TL;DR
Turn your wind-down time into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Craig Hockenberry’s Oct. 28 personal update describes his lymphoma treatment, including chemotherapy that ended in May, a serious pneumonia episode in March and later sensations he interpreted as signs of nerve recovery. The report does not provide a current medical assessment, prognosis or details of his lymphoma diagnosis.
Craig Hockenberry published a personal update on Oct. 28 describing his treatment for lymphoma, including chemotherapy that ended in May, a bout of pneumonia during treatment and what he believes may be signs of recovery from nerve damage. His account offers a first-person view of the effects he experienced, but does not give a current clinical assessment or prognosis.
Hockenberry said an early part of treatment involved weekly lumbar punctures over six weeks, ending in late January. He wrote that doctors removed spinal fluid for analysis and replaced it with methotrexate. He described severe headaches afterward, which he said improved when he lay flat, and said they subsided after the course ended.
He later received bendamustine and rituximab infusions on a 28-day cycle. In his account, side effects included altered taste, fatigue, muscle loss and a 50-pound weight loss over a couple of months. He said he did not experience nausea or hair loss, though his hair lost its usual volume. His personal experience should not be taken as representative of how other patients respond to treatment.
In March, Hockenberry said he developed pneumonia while his immune system was weakened. He reported low blood-oxygen levels and an atrial fibrillation alert from his Apple Watch; he said antibiotics treated the pneumonia. He wrote that his doctor offered to skip the next chemotherapy cycle, but he chose to continue. After his final infusion in May, he said his appetite, strength and stamina gradually improved.
Treatment Effects and Recovery
The account shows how cancer treatment can affect daily function as well as appetite and energy. Hockenberry described needing walking sticks for balance and struggling with stairs while experiencing nerve symptoms. He also recounted a serious infection during chemotherapy, a period when the body’s ability to fight infection can be reduced. His account is an individual experience, not a guide to predicting another patient’s risks or outcomes.
His report also draws attention to a recovery question that remains unresolved for him: whether the nerve damage that affected his gait and sensation will continue to improve. He described a new sensation down the backs of his legs after a walk and said he came to view it as a sign that nerves were recovering. That interpretation is his own; the post does not include a clinician’s confirmation or test results.
Products Worth Considering
Blueair Blue Pure 511i Max Air Purifier for Home and Bedroom
BowFlex SelectTech 840 Adjustable Kettlebell
Garmin Venu 3 Fitness Smartwatch, 45 mm, Black
As an affiliate, we earn on qualifying purchases.
From January Treatment to May
Hockenberry’s post recounts a sequence of treatment and recovery milestones rather than announcing a new diagnosis or clinical finding. He describes spinal-fluid procedures through January, chemotherapy infusions afterward, a pneumonia episode in March and the end of infusions in May. The article was published months after those events, on Oct. 28, and presents them retrospectively.
He said chemotherapy affected his taste and energy, and that his metabolism seemed to be working faster than his food intake could match. He responded by increasing the number of meals he ate, while daily walks became a way to maintain activity despite fatigue and impaired balance. He credited his wife with finding walking sticks that helped him walk more safely. These are details of his own coping routine, not medical recommendations.
“I’m writing this post from a hospital bed. And I couldn’t be happier.”
— Craig Hockenberry
Nerve Recovery Still Unverified
The post does not identify the lymphoma subtype, provide test results or explain the full treatment plan. It also does not state whether Hockenberry is currently in remission, what his latest clinical assessment found, or whether additional treatment is planned. His description of a new sensation as evidence that nerves were repairing is a personal interpretation; the account gives no medical confirmation, examination findings or prognosis. The cause and extent of the nerve damage are not detailed in the supplied report.
Further Clinical Updates Awaited
Hockenberry’s post does not announce a specific next appointment, treatment milestone or follow-up date. Any further information about his recovery, lymphoma status or nerve function would need to come from him or his medical team. For now, the latest information in the account is that he had completed infusions in May and described gradual improvement afterward.
Key Questions
What health update did Craig Hockenberry share?
He described lymphoma treatment, side effects from chemotherapy, pneumonia during treatment and gradual recovery after his final infusion in May. He also reported sensations he interpreted as possible nerve recovery.
What chemotherapy drugs did Hockenberry name?
He said his infusions included bendamustine and rituximab. He also described earlier lumbar punctures in which methotrexate was placed into spinal fluid.
What complication did he report during treatment?
Hockenberry said he developed pneumonia in March while his immune system was weakened. He reported low blood-oxygen levels and an Apple Watch alert for atrial fibrillation, and said antibiotics treated the pneumonia.
Does the post confirm that his nerve damage has healed?
No. Hockenberry described a new sensation that he believed could signal nerve repair, but the post does not provide medical confirmation, test results or a prognosis.
Source: furbo.org
